Epalrestat
Inquiry
| Post Date: | Jan 05,2013 |
| Expiry Date: | Jan 05,2014 |
| Detailed Description: | Cas No. :82159-09-9 Epalrestat is an aldose reductase inhibitor for the treatment of diabetic neuropathy. |
| CAS Registry Number: | 82159-09-9 |
| Synonyms: | ;Epalrestat [INN];Ono 2235;5-((1Z,2E)-2-Methyl-3-phenylpropenylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid;5-((Z,E)-beta-Methylcinnamylidene)-4-oxo-2-thioxo-3-thiazolidineacetic acid;Epalrestatum;Epalrestatum [Latin];UNII-424DV0807X;3-Thiazolidineacetic acid, 5-(2-methyl-3-phenyl-2-propenylidene)-4-oxo-2-thioxo-, (E,E)-;{(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid;{(5E)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid;Kinedak; |
| Molecular Formula: | C15H13NO3S2 |
| Molecular Weight: | 319.3986 |
| Molecular Structure: | 
|
| Company: | Pioneers Group |
| Contact: | Summer |
| Tel: | 0086-025-68520566 |
| Fax: | - |
| Email: | zhaojinfangzjf@126.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
